Context
- The AYUSH Ministry budget has nearly doubled in the last five years, reaching ₹4,408 crore in 2026–27, reflecting a clear policy shift towards mainstreaming traditional medicine. The India–EU Free Trade Agreement (FTA) along with the Union Budget signals Ayurveda’s transition from domestic relevance to global expansion, combining internal strengthening with international outreach.
Key Developments in the AYUSH Sector
- Three new All-India Institutes of Ayurveda have been announced on the AIIMS model, integrating treatment, education, and advanced research within a single institutional framework.
- The National AYUSH Mission funding has increased by 66%, aimed at modernising dispensaries, establishing AYUSH units within government hospitals, and strengthening drug-testing laboratories.
- The policy approach is shifting towards integrating AYUSH into mainstream healthcare delivery, rather than treating it as a parallel or alternative system.
- Global Expansion through India–EU FTA
- In EU countries where traditional medicine is not specifically regulated, the agreement allows Indian AYUSH practitioners to offer services using Indian qualifications.
- Indian firms can now establish Ayurvedic clinics across Europe with regulatory certainty, reducing risks of sudden policy reversals.
- A framework is being developed for mutual recognition of safety certifications, which could reduce duplication in testing requirements.
- AYUSH systems will be evaluated under stringent international regulatory frameworks (TCAM), making scientific validation and accountability unavoidable.
Significance of AYUSH
- AYUSH provides a holistic model of healthcare, where the body is seen as an interconnected system influenced by environment, diet, and lifestyle.
- It complements modern biomedicine by focusing on preventive and equilibrium-based health, rather than only disease treatment.
- The sector holds strong potential for exports, employment generation, and wellness tourism, contributing to India’s economic growth.
- AYUSH enhances India’s soft power and cultural diplomacy, projecting traditional knowledge systems globally.
- It positions India as a potential leader in integrative healthcare, combining traditional wisdom with modern scientific approaches.
Key Challenges
- Many AYUSH studies are funded and supervised by the same institutions that promote it, creating a conflict of interest that undermines credibility.
- There is a lack of independent clinical trials, transparent methodologies, and peer-reviewed evidence, which weakens acceptance in global markets.
- Strict international standards require high-quality manufacturing, safety validation, and claim verification, which remain inconsistent.
- If claims are not supported by evidence, India risks legal challenges, reputational damage, and global scepticism about traditional medicine.
- There is also a conceptual challenge in reconciling holistic AYUSH frameworks with reductionist biomedical models.
Way Forward
- India must promote independent, third-party research to ensure unbiased and scientifically credible validation of AYUSH systems.
- There is a need to align AYUSH products with global regulatory standards on safety, quality, and efficacy to ensure smooth international acceptance.
- Institutional reforms should ensure a clear separation between promotion and evaluation functions to enhance trust.
- An integrative healthcare approach should be encouraged, where AYUSH and modern medicine coexist and complement each other.
- India must build global credibility through evidence, transparency, and rigorous scientific examination, rather than relying solely on cultural assertion.
Conclusion
- The AYUSH sector represents a unique convergence of heritage, healthcare, and economic opportunity. Its global success will depend on India’s ability to balance traditional knowledge with scientific rigor, ensuring credibility, safety, and sustainability in international markets.